Enhanced production of osteopontin in multiple myeloma: Clinical and pathogenic implications

British Journal of Haematology

Volumn 123, Issue 2, 2003, Pages 263-270

  Saeki, Yukihiko ^a,b,h   Mima, Toru ^a,b   Ishii, Taeko ^a   Ogata, Atsushi ^c   Kobayashi, Hideyuki ^a   Ohshima, Shiro ^a   Ishida, Tetsushi ^a   Tabunoki, Yuichiro ^a   Kitayama, Hitoshi ^a   Mizuki, Masao ^a   Katada, Yoshinori ^b   Asaoku, Hideki ^d   Kitano, Masayasu ^c   Nishimoto, Norihiro ^e   Yoshizaki, Kazuyuki ^e   Maeda, Masahiro ^f   Kon, Shigeyuki ^g   Kinoshita, Naokazu ^b   Uede, Toshimitsu ^g   Kawase, Ichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f Immuno Biological Laboratories Co Ltd   (Japan)

^g HOKKAIDO UNIVERSITY   (Japan)

^h MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Bone resorption; Monoclonal gammopathy of undetermined significance (MGUS); Multiple myeloma; Osteoclast; Osteopontin

Indexed keywords

OSTEOPONTIN;

ARTICLE; B LYMPHOCYTE; BONE DESTRUCTION; BONE MARROW CELL; CANCER CELL CULTURE; CELL CULTURE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BONE MARROW CELLS; BONE RESORPTION; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOPLASM STAGING; OSTEOPONTIN; PARAPROTEINEMIAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0142215535     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04589.x     Document Type: Article

References (36)

1. Adatia, A.K. (1968) Dental tissues and Burkitt's tumor. Oral Surgery, 25, 221-234.
2. Bataille, R. & Klein, B. (1991) The bone resorbing activity of interleukin-6. Journal of Bone and Mineral Research, 9, 1143-1146.
3. Bataille, R., Jourdan, M., Zhang, X.G. & Klein, B. (1989) Serum levels of interleukin-6, a potent myeloma growth factor, as a reflection of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation, 84, 2008-2011.
4. Bataille, R., Chappard, D. & Klein, B. (1992) Mechanisms of bone lesions in multiple myeloma. Hematology/Oncology Clinics of North America, 6, 285-295.
5. Bertolini, D.R., Nedwin, G.E., Bringam, T.S., Smith, D.D. & Mundy, G.R. (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature, 319, 516-518.
6. Billadeau, D., Van Ness, B., Kimlinger, T., Kyle, R.A., Therneau, T.M., Greipp, P.R. & Witzig, T.E. (1996) Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood, 88, 289-296.
7. Cozzolino, F., Torcia, M., Aldinucci, D., Rubartelli, A., Miliani, A., Shaw, A.R., Lansdorp, P.M. & DiGuglielmo, R. (1989) Production of interleukin-1 by bone marrow cells. Blood, 74, 380-387.
8. Crippes, B.A., Engleman, V.W., Settle, S.L., Delarco, J., Ornberg, R.L., Helfrich, M.H., Horton, M.A. & Nickols, G.A. (1996) Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology, 137, 918-924.
9. Croucher, P.I., Shipman, C.M., Lippitt, J. & Perry, M. (2001) Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. Blood, 98, 3534-3540.
10. Denhardt, D.T. & Gou, X. (1993) Osteopontin: a protein with diverse functions. FASEB Journal, 7, 1475-1482.
11. Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
12. Durie, B., Salmon, S.E. & Mundy, G.R. (1981) Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. British Journal of Haematology, 47, 21-30.
13. Garrett, I.R., Durie, B.G., Nedwin, G.E., Gillespie, A., Bringman, T., Sabatini, M., Bertolini, D.R. & Mundy, G.R. (1987) Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. New England Journal of Medicine, 317, 526-532.
14. Grigoriadis, A.E., Wang, Z.Q., Cecchini, M.G., Hofstetter, W., Felix, R., Fleisch, H.A. & Wagner, E.F. (1994) C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science, 266, 443-448.
15. Ihara, H., Denhardt, D.T., Furuya, K., Yamashita, T., Muguruma, Y., Tsuji, K., Hruska, K.A., Higashio, K., Enomoto, S., Nifuji, A., Rittling, S.R. & Noda, M. (2001) Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. Journal of Biological Chemistry, 276, 13065-13071.
16. Kon, S., Maeda, M., Segawa, T., Hagiwara, Y., Horikoshi, Y., Chikuma, S., Tanaka, K., Rashid, M.H., Inobe, M., Chanbers, A.F. & Uede, T. (2000) Antibodies to different peptides in osteopontin reveal complexities in the variants secreted forms. Journal of Cell Biochemistry, 77, 487-498.
17. Kon, S., Yokosaki, Y., Maeda, M., Segawa, T., Horikoshi, Y., Tsukagoshi, H., Rashid, M.H., Morimoto, J., Inobe, M., Shijubo, N., Chambers, A.F. & Uede, T. (2002) Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. Journal of Cell Biochemistry, 84, 420-432.
18. Kyle, R.A. (1992) Diagnostic criteria of multiple myeloma. Hematology/Oncology Clinics of North America, 6, 347-358.
19. Kyle, R.A. & Lust, J.A. (1989) Monoclonal gammopathies of undetermined significance. Seminars in Hematology, 26, 176-200.
20. McHugh, K.P., Hodivala-Dilke, K., Zheng, M.H., Namba, N., Law, J., Novack, D., Feng, X., Ross, F.P., Hynes, R.O. & Teitelbaum, S.L. (2000) Mice lacking beta 3 integrins are osteosclerotic because of dysfunctional osteoclasts. Journal of Clinical Investigation, 105, 433-440.
21. Matsumoto, M., Sakao, Y. & Akira, S. (1998) Inducible expression of nuclear factor IL-6 increase endogenous gene expression of macrophage inflammatory protein-α, osteopontin, and CD14 in a monocytic leukemia cell line. International Immunology, 10, 1825-1835.
22. Matsuo, Y. & Drexler, H.G. (1998) Establishment and characterization of human B cell precursor-leukemia cell lines. Leukemia Research, 22, 567-579.
23. Miyauchi, A., Alvarez, J., Greenfield, E.M., Teti, A., Grano, M., Colucci, S., Zambonin-Zallone, A., Ross, F.P., Teitelbaum, S.L. & Cheresh, D. (1991) Recognition of osteopontin and related peptides by αvβ3 integrin stimulate cell signals in osteoclasts. Journal of Biological Chemistry, 266, 20369-20374.
24. Mundy, G.R., Raisz, L.G., Cooper, R.A., Schechter, G.P. & Salmon, S.E. (1974) Evidence for the secretion of an osteoclast stimulating factor in myeloma. New England Journal of Medicine, 29, 1041-1046.
25. Ohshima, S., Kobayashi, H., Yamaguchi, N., Nishioka, K., Umeshita-Sasai, M., Mima, T., Nomura, S., Kon, S., Inobe, M., Uede, T. & Saeki, Y. (2002a) Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis; possible involvement of osteopontin in bone destruction in arthritis. Arthritis and Rheumatism, 46, 1094-1101.
26. Ohshima, S., Yamaguchi, N., Nishioka, K., Mima, T., Ishii, T., Umeshita-Sasai, M., Kobayashi, H., Shimizu, M., Katada, Y., Wakitani, S., Murata, N., Nomura, S., Matsuno, H., Katayama, R., Kon, S., Inobe, M., Uede, T., Kawase, I. & Saeki, Y. (2002b) Enhanced local production of osteopontin in rheumatoid joints. Journal of Rheumatology, 29, 2061-2067.
27. Oldberg, A., Franzen, A. & Heinegard, D. (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. Proceedings of the National Academy of Science of the USA, 83, 8819-8823.
28. Otsuki, T., Yamada, O., Kurebayashi, J., Sakaguchi, H., Yata, K., Uno, M., Oka, T., Yawata, Y. & Ueki, A. (2001) Expression and in vitro modification of parathyroid hormone-related protein (PTH-rP) and PTH/PTH-rP receptor in human myeloma cells. Leukemia and Lymphoma, 41, 397-409.
29. Petrow, P.K., Hummel, K.M., Schedel, J., Franz, J.K., Klein, C.L., Muller-Ladner, U., Kriegsmann, J., Chang, P.L., Prince, C.W., Gay, R.E. & Gay, S. (2000) Expression of osteopontin messenger RNA and protein in rheumatoid arthritis. Arthritis and Rheumatism, 43, 1597-1605.
30. Prince, C.W., Oosawa, T., Butler, W.T., Tomana, M., Bhown, M. & Schrohenloher, R.E. (1987) Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. Journal of Biological Chemistry, 262, 2900-2907.
31. Reinholt, F.P., Hultenby, K., Oldberg, A. & Heinegard, D. (1990) Osteopontin - a possible anchor of osteoclast to bone. Proceedings of the National Academy of Science of the USA, 87, 4473-4475.
32. Roodman, G.D. (1997) Mechanisms of bone lesion in multiple myeloma and lymphoma. Cancer, 80 (Suppl.), 1557-1563.
33. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. (1991) Targeted disruption of the C-src proto-oncogene leads to osteopetrosis in mice. Cell, 64, 693-702.
34. Tondravi, M.M., McKercher, S.R., Anderson, K., Erdmann, J.M., Quiroz, M., Maki, R. & Teitelbaum, S.L. (1997) Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature, 386, 81-84.
35. Yoshitake, H., Rittling, S.R., Denhardt, D.T. & Noda, M. (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proceedings of the National Academy of Science of the USA, 96, 81560-81560.
36. Yumoto, K., Ishigami, M., Rittling, S.R., Tsuji, K., Tsuchiya, Y., Kon, S., Nifuji, A., Uede, T., Denhardt, D.T. & Noda, M. (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody induced arthritis in mice. Proceedings of the National Academy of Science of the USA, 99, 4556-4561.